Traditional Culture vs mNGS: A Data-Driven Comparison for Clinical Labs
For Labs Evaluating a Move From Culture to mNGS
If you are a lab director or clinical microbiologist deciding whether metagenomic next-generation sequencing (mNGS) earns a place alongside blood culture, the question is not “is mNGS more sensitive in theory” — it is whether the diagnostic yield, turnaround, and cost-per-result justify the workflow change for your specific samples. This page leads with head-to-head clinical data rather than general claims.
- Sample and case fit: sepsis and bloodstream infection, culture-negative presentations, polymicrobial infection, and patients already started on empiric antibiotics.
- What changes: diagnostic yield on hard cases, time to an actionable result, and the cost structure of sequencing once host DNA is removed.
- What does not change: culture remains the reference for susceptibility testing and for organisms where phenotypic data drives therapy.
- Recommended next step: Request a workflow consultation to map this comparison onto your sample types.
The comparisons below draw on the Taipei Veterans General Hospital sepsis evaluation and a peer-reviewed sepsis cohort, both run on the PaRTI-Seq workflow with Devin host depletion.
Diagnostic Yield: Culture vs mNGS in the Same Patients
The most useful comparison data comes from studies that run culture and mNGS on the same patients. In the TVGH evaluation of septic patients (50 analyzed, 45 with complete results), the host-depleted mNGS workflow produced the highest positive-identification rate of any method tested:
- PaRTI-Seq (host-depleted gDNA mNGS): 74.4%
- mNGS without host depletion: 51.1%
- First blood culture (BC1): 50.0%
- Second blood culture (BC2): 22.0%
Two findings matter for a method decision. First, mNGS without host depletion barely matched first-draw blood culture (51.1% vs 50.0%) — host DNA interference erases most of the theoretical advantage of sequencing, which is why depletion is not optional for blood. Second, the second blood culture, drawn after antibiotic exposure, fell to 22.0% positivity, while the host-depleted mNGS workflow held at 74.4% on the same draws. For patients already on empiric antibiotics — the majority of sepsis presentations — culture loses ground that sequencing does not.
Using the second blood culture as reference, sensitivity was 81.8% for the PaRTI-Seq workflow versus 63.6% for mNGS without filtration. A separate peer-reviewed cohort of eight culture-positive sepsis patients reinforced this: host-depleted gDNA mNGS detected the expected pathogen in 100% (8/8) of samples, raising average microbial reads from 925 to 9,351 reads per million — a greater than tenfold enrichment.
Why Host Depletion Decides the Comparison
The reason untreated mNGS underperforms is mechanical, not biological. In whole blood, human DNA can exceed 99% of total genomic content, so without depletion the sequencer spends its capacity reading the host genome instead of the pathogen. Removing host cells before extraction is what converts mNGS from a theoretical advantage into a measured one.
The Devin Host Depletion Filter removes more than 99% of white blood cells in under five minutes with no reagents or enzymes, while preserving greater than 90% microbial pass-through. Critically for diagnostic use, depletion did not distort which organisms were detected — the TVGH study reported an R² of 0.96 between filtered and unfiltered microbial composition. You gain signal without changing the answer. For how charge-based filtration compares with enzymatic and other depletion chemistries, see XNA vs enzymatic host depletion and the benchmarking review of host depletion approaches.
Turnaround Time: Days vs Within 24 Hours
Blood culture is a multi-day process by design: it depends on organisms growing to detectable density, followed by subculture, identification, and susceptibility testing. For slow-growing or fastidious organisms, and for patients on antibiotics, that timeline stretches or never produces a positive at all.
The host-depleted mNGS workflow in the TVGH study delivered results within 24 hours, independent of whether the organism grows in culture. Within that workflow, the PaRTI-Seq Clinical Analysis step adds roughly 30 minutes of analysis per sample and does not require a dedicated bioinformatician for the clinical configuration. The decision is less “is sequencing faster than culture in every case” and more “for time-critical or culture-negative cases, can you afford to wait for growth that may not come.”
Cost Per Actionable Result, Not Cost Per Test
mNGS is often dismissed as too expensive, but the relevant figure is cost per actionable result — the cost of reaching a usable answer, including the cases culture never resolves. Host depletion changes this math directly: by clearing host reads, the workflow reaches a confident call at far lower sequencing depth.
In Micronbrane’s value model on an Illumina MiniSeq, the host-depleted workflow required 5 million reads per sample versus 20 million without it, modeling to $537.28 per sample with PaRTI-Seq versus $1,729.11 without — up to a 75% reduction. These are model outputs for a specific instrument and read configuration, not a universal price, but the direction holds: depletion lowers the per-result cost of sequencing while raising yield. Against culture, the comparison must also count the indirect cost of delayed or absent diagnosis — prolonged empiric therapy, longer stays, and repeat testing — which rarely appears on a per-test line item.
Polymicrobial and Culture-Negative Cases
The cases where the method choice matters most are precisely those where culture is weakest:
- Culture-negative infection: when prior antibiotics suppress growth, culture positivity drops sharply (22.0% on second draw in the TVGH cohort) while sequencing detects residual pathogen DNA.
- Polymicrobial infection: culture tends to recover the fastest-growing organism and can mask co-infections; untargeted sequencing reports the full community present.
- Fastidious or slow-growing organisms: mNGS does not depend on culturability, so organisms that resist standard media are still detectable.
- Low-biomass specimens: for samples where microbial DNA is scarce after depletion, the Unison Ultralow DNA NGS Library Prep Kit constructs libraries from inputs as low as 10 pg, preserving the depletion advantage through to sequencing.
This is also where mNGS and culture are complementary rather than competing: culture still anchors phenotypic susceptibility testing, while sequencing closes the diagnostic gaps culture leaves open.
Decision Framework: Which Method for Which Case
The practical model for most labs is not replacement but addition: keep culture for what it does best, and add a host-depleted mNGS path for the cases where culture yield, speed, or breadth fall short.
Take the Next Step
If you are scoping a method transition, the fastest way to evaluate fit is to map this comparison onto your actual sample types, antibiotic-exposure patterns, and turnaround requirements.
- Request a workflow consultation to discuss your sample types and case mix.
- Review the underlying evidence: TVGH sepsis mNGS research summary and cell-free vs genomic DNA mNGS assays.
- Explore the workflow: PaRTI-Seq, Devin Host Depletion, and Unison library prep.
